| | | | |
CUSIP No. 69954Q105 | | 13G | | Page 8 of 13 Pages |
Item 1(a). | Name of Issuer: |
Pardes Biosciences, Inc.
Item 1(b). | Address of Issuer’s Principal Executive Officers: |
2173 Salk Avenue, Suite 250
PMB#052
Carlsbad, California 92008
Item 2(a). | Name of Person(s) Filing: |
Khosla Ventures Seed D, LP (“Seed D”)
Khosla Ventures VII, LP (“KV VII”)
Khosla Ventures Seed Associates D, LLC (“KVSA D”)
Khosla Ventures Associates VII, LLC (“KVA VII”)
VK Services, LLC (“VK Services”)
Vinod Khosla (“Khosla”)
Item 2(b). | Address of Principal Business Office: |
Khosla Ventures
2128 Sand Hill Road
Menlo Park, California 94025
| | |
Seed D | | Delaware, United States of America |
KV VII | | Delaware, United States of America |
KVA VII | | Delaware, United States of America |
KVSA D | | Delaware, United States of America |
VK Services | | Delaware, United States of America |
Khosla | | United States of America |
Item 2(d). | Title of Class of Securities: |
Common Stock, par value $0.0001 per share.
69954Q105
Item 3. | If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: |
Not applicable.